ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools market, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Frequently asked questions
What sector does Arcticzymes Technologies ASA (AZT) operate in?
Arcticzymes Technologies ASA belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Arcticzymes Technologies ASA (AZT) current stock price?
As of the latest data, Arcticzymes Technologies ASA stock price is NOK 20.50, with a previous close of NOK 19.45. Arcticzymes Technologies ASA gained NOK 1.05 in the last trading session, representing a 5.4% increase.
What is Arcticzymes Technologies ASA (AZT) current market capitalization?
Arcticzymes Technologies ASA market cap is approximately 1.05 billion.
What is Arcticzymes Technologies ASA (AZT) Earnings Per Share (EPS)?
The trailing EPS is NOK 0.26, and the forward EPS is NOK 0.63.
What is Arcticzymes Technologies ASA (AZT) Price-to-Earnings (P/E) ratio?
Arcticzymes Technologies ASA current P/E ratio is 78.85, with a forward P/E of 32.59.
Does Arcticzymes Technologies ASA (AZT) pay dividends?
No. Arcticzymes Technologies ASA does not pay a dividend.
When is Arcticzymes Technologies ASA (AZT) next earnings report?
Arcticzymes Technologies ASA is expected to release its next earnings report on June 30, 2026.
What is Arcticzymes Technologies ASA (AZT) beta (volatility) score?
Arcticzymes Technologies ASA has a beta of 0.552, indicating lower volatility than the overall market.
